Alvar Aallon katu 1
P.O. Box 380
00101 Helsinki, Finland
Stay up to date with UPM Biomedicals
Our latest press releases
UPM brings its first clinical product to market – FibDex® wound dressing
(UPM, Helsinki, 20.8.2020 at 10:00 EET) FibDex ® wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device distributor Steripolar Oy now sells the product ...
UPM Biomedicals to advance cancer immunotherapies in Finnish Cancer IO project
(UPM, Helsinki, 19 May 2020 at 10:00 EET) – UPM Biomedicals takes part in a new cancer immunotherapy focused top-level collaborative research and innovation project, Cancer IO. The Cancer IO project starts as part of Business Finland’s Personalize...
New Director for UPM Biomedicals
(UPM, Helsinki, 4 May 2020) - Johana Kuncova-Kallio has been appointed Director, UPM Biomedicals as of 4 of May 2020. She will be responsible for leading and developing UPM Biomedicals business. Johana is joining UPM from BioNavis Ltd where she h...
UPM and Nichirei Biosciences announce partnership to supply Japanese 3D cell culture market with GrowDex® advanced natural hydrogels
(UPM, Helsinki, 13 March 2020 at 09:00 EET) - UPM Biomedicals and Nichirei Biosciences Inc. have signed an agreement on 1 March, 2020 to offer the full range of UPM cell culture products to life sciences researchers in Japan. This agreement will...